These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6611437

  • 1. Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.
    Hanaue H, Kurosawa T, Yoshizaki S, Shikata J.
    Jpn J Surg; 1984 May; 14(3):191-7. PubMed ID: 6611437
    [Abstract] [Full Text] [Related]

  • 2. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
    Hanaue H, Nomoto S, Seto A, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):1975-85. PubMed ID: 7169568
    [No Abstract] [Full Text] [Related]

  • 3. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H, Nomoto S, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Keio J Med; 1982 Dec 20; 31(4):159-68. PubMed ID: 6985379
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.
    Hanaue H, Kurosawa T, Yasuda H, Yoshizaki S, Nomoto SN, Takada T, Shikata J.
    Keio J Med; 1984 Apr 20; 33(1):17-27. PubMed ID: 6482140
    [No Abstract] [Full Text] [Related]

  • 5. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
    Hanaue H, Kurosawa T, Kitano Y, Miyagawa S, Nemoto A, Yamato H, Asagoe T, Shikata J.
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug 20; 22(7):1367-72. PubMed ID: 3501455
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 7. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):930-4. PubMed ID: 6721507
    [Abstract] [Full Text] [Related]

  • 8. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
    Torisu M, Katano M, Kimura Y, Itoh H, Takesue M.
    Surgery; 1983 Mar 20; 93(3):357-64. PubMed ID: 6187080
    [No Abstract] [Full Text] [Related]

  • 9. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.
    Yamagishi H, Ishibashi H, Kodama M, Tanaka T, Harada Y, Hashimoto I.
    Jpn J Surg; 1982 May 20; 12(6):434-41. PubMed ID: 7166915
    [Abstract] [Full Text] [Related]

  • 14. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of endoscopic injections of OK-432 in the treatment of gastric cancer.
    Nakazawa S, Yoshino J, Okamura S, Yamao K.
    Scand J Gastroenterol; 1988 Jun 20; 23(5):539-45. PubMed ID: 3041555
    [Abstract] [Full Text] [Related]

  • 16. Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro.
    Uchida A, Hoshino T.
    Cancer; 1980 Feb 20; 45(3):476-83. PubMed ID: 6965464
    [Abstract] [Full Text] [Related]

  • 17. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr 20; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M.
    Fukuoka Igaku Zasshi; 1981 Oct 20; 72(10):543-55. PubMed ID: 7327499
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.